tiprankstipranks
Advertisement
Advertisement

VOR Stock Latest News

Vor Biopharma Advances Phase 3 Telitacicept Trial in Myasthenia Gravis, Keeping Investor Focus High
Company AnnouncementsVor Biopharma Advances Phase 3 Telitacicept Trial in Myasthenia Gravis, Keeping Investor Focus High
3d ago
VOR
Vor Bio files to sell 5.34M shares of common stock for holders
PremiumThe Fly
Vor Bio files to sell 5.34M shares of common stock for holders
14d ago
VOR
Clene, Lovesac, HDFC Bank, State Street, Vor Shock
PremiumWeekend Updates
Clene, Lovesac, HDFC Bank, State Street, Vor Shock
16d ago
HDB
STT
Bj’s, Atlas, Academy, Vor, Global-e: Insider Shakeup
PremiumWeekend Updates
Bj’s, Atlas, Academy, Vor, Global-e: Insider Shakeup
23d ago
BJ
ASO
Vor Bio price target lowered to $31 from $32 at H.C. Wainwright
PremiumThe Fly
Vor Bio price target lowered to $31 from $32 at H.C. Wainwright
26d ago
VOR
Elbit, Vor, Global-e, Sweetgreen, Immunovant: Insider Shake-Up
PremiumWeekend UpdatesElbit, Vor, Global-e, Sweetgreen, Immunovant: Insider Shake-Up
30d ago
SG
VOR
Vor Bio price target raised to $15 from $9 at Wedbush
Premium
The Fly
Vor Bio price target raised to $15 from $9 at Wedbush
1M ago
VOR
Vor Bio price target lowered to $40 from $55 at Stifel
Premium
The Fly
Vor Bio price target lowered to $40 from $55 at Stifel
1M ago
VOR
Vor Bio price target lowered to $40 from $55 at Stifel
PremiumThe Fly
Vor Bio price target lowered to $40 from $55 at Stifel
1M ago
VOR
Vor Biopharma: Solid Clinical Execution and Strengthened Balance Sheet Support Buy Rating and Long-Term Growth Outlook
PremiumRatings
Vor Biopharma: Solid Clinical Execution and Strengthened Balance Sheet Support Buy Rating and Long-Term Growth Outlook
1M ago
VOR
Vor Bio doses first patient in UPSTREAM SjD study
PremiumThe Fly
Vor Bio doses first patient in UPSTREAM SjD study
1M ago
VOR
Vor Bio initiated with a Buy at Jefferies
PremiumThe Fly
Vor Bio initiated with a Buy at Jefferies
1M ago
VOR
Vor Biopharma: Strategic Autoimmune Pivot and Telitacicept’s >$2B gMG/SjD Opportunity Underpins Buy Rating
PremiumRatingsVor Biopharma: Strategic Autoimmune Pivot and Telitacicept’s >$2B gMG/SjD Opportunity Underpins Buy Rating
1M ago
VOR
Vor Biopharma Announces $75 Million Private Placement Financing
Premium
Company Announcements
Vor Biopharma Announces $75 Million Private Placement Financing
1M ago
8K
VOR
Vor Bio to sell 5.338M shares at $14.05 in private placement
Premium
The Fly
Vor Bio to sell 5.338M shares at $14.05 in private placement
1M ago
VOR
Vor Bio initiated with an Overweight at Wells Fargo
PremiumThe Fly
Vor Bio initiated with an Overweight at Wells Fargo
2M ago
VOR
VOR Earnings this Week: How Will it Perform?
PremiumPre-Earnings
VOR Earnings this Week: How Will it Perform?
2M ago
VOR
Galapagos CHRO Annelies Missotten to step down, Tania Philipp to succeed
PremiumThe Fly
Galapagos CHRO Annelies Missotten to step down, Tania Philipp to succeed
2M ago
VOR
GLPG
Vor Bio files to sell 13.88M shares of common stock for holders
PremiumThe Fly
Vor Bio files to sell 13.88M shares of common stock for holders
3M ago
VOR
Vor Biopharma to Highlight Telitacicept at JPM Conference
PremiumCompany AnnouncementsVor Biopharma to Highlight Telitacicept at JPM Conference
4M ago
8K
VOR
Vor Bio initiated with a Buy at Citi
Premium
The Fly
Vor Bio initiated with a Buy at Citi
4M ago
VOR
Vor Biopharma CDO Departs, Transition Support Planned
Premium
Company Announcements
Vor Biopharma CDO Departs, Transition Support Planned
4M ago
8K
VOR

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >